Two-year clinical outcomes after successful transcatheter aortic valve implantation with balloon-expandable versus self-expanding valves: A subanalysis of the GALILEO trial.
Taishi OkunoGeorge D DangasChristian HengstenbergSamantha SartoriHoward C HerrmannRobert de WinterMartine GilardDidier TchétchéHelge MöllmannRaj R MakkarStephan BaldusOle de BackerBjørn BendzAnnapoorna S KiniDirk von LewinskiMichael MackRaul MorenoUlrich SchäferJochen WöhrleJulia SeegerClayton SnyderJohny NicolasJan G P TijssenRobert C WelshPascal VranckxMarco ValgimigliRoxana MehranSamir R KapadiaLars SondergaardStephan WindeckerPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2022)
Two-year follow-up data from the GALILEO trial indicate that successful TAVI either with self-expanding or balloon-expandable THVs according to physician discretion did not show difference in rates of MACCE.
Keyphrases
- transcatheter aortic valve implantation
- aortic valve
- aortic valve replacement
- aortic stenosis
- phase iii
- study protocol
- transcatheter aortic valve replacement
- phase ii
- clinical trial
- emergency department
- primary care
- electronic health record
- ejection fraction
- open label
- left ventricular
- big data
- randomized controlled trial
- artificial intelligence
- heart failure